Pharmaids Pharmaceuticals has appointed Dr. Yogananda Moolemath, an experienced toxicologist with over 30 years in drug discovery and development, as an Independent Director for a five-year term starting January 1, 2026, pending shareholder approval. In a leadership transition, Dr. S. N. Vinaya Babu stepped down as Chairman to assume the role of Vice Chairman. Mr. P. N. Vijay, an Independent Director boasting 50 years of expertise in investment banking and corporate governance, now serves as the new Chairman of the Board, effective December 5, 2025. These changes aim to bolster board governance and strategic oversight.